List of works - Hiroaki Akamatsu

A Phase II Study of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer who Responded to Prior PD-1/L1 Inhibitors: West Japan Oncology Group 9616L (WJOG9616L)

scientific article published on 11 December 2018

Chemoradiotherapy for Limited-disease Small-cell Lung Cancer in Elderly Patients Aged 75 Years or Older ⬇️

scientific article published on 05 December 2012

Clinical significance of monitoring EGFR mutation in plasma using multiplexed digital PCR in EGFR mutated patients treated with afatinib (West Japan Oncology Group 8114LTR study)

scientific article published on 22 March 2019

Detection of AXL expression in circulating tumor cells of lung cancer patients using an automated microcavity array system

scientific article published on 30 January 2020

Differential efficacy of docetaxel according to non-small cell lung cancer histology and the therapeutic effect of epidermal growth factor receptor tyrosine kinase inhibitors ⬇️

scientific article published on August 31, 2011

EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer

scientific article published on 01 November 2018

Efficacy of Rechallenge Chemotherapy in Patients With Sensitive Relapsed Small Cell Lung Cancer ⬇️

scientific article published on 01 February 2015

Efficacy of bevacizumab-containing chemotherapy for non-squamous non-small cell lung cancer with bone metastases ⬇️

scientific article published on March 27, 2013

Exploration of resistance mechanisms for EGFR-TKIs based on plasma analysis by digital PCR and next-generation sequencing

scientific article published on 13 November 2018

Feasibility of postoperative adjuvant chemotherapy of cisplatin plus vinorelbine for completely resected non-small-cell lung cancer: A retrospective study in Japan ⬇️

scientific article published on October 27, 2012

Furosemide versus mannitol in Japanese patients with thoracic malignancy who received cisplatin-based chemotherapy using short hydration: study protocol for a randomised controlled trial

scientific article published on 11 December 2019

Immune-Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non-Small Cell Lung Cancer

scientific article published on 19 November 2019

Intestinal metastasis from non-small-cell lung cancer initially detected by 18F-fluorodeoxyglucose positron emission tomography ⬇️

scientific article published on November 27, 2010

Nivolumab Retreatment in Non–Small Cell Lung Cancer Patients Who Responded to Prior Immune Checkpoint Inhibitors and Had ICI-Free Intervals (WJOG9616L)

scientific article published on 28 June 2022

Osimertinib in Japanese patients with EGFR T790M mutation-positive advanced non-small cell lung cancer: AURA3 trial.

scientific article published on 26 April 2018

Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M-positive non-small cell lung cancer: West Japan Oncology Group 8815L/LPS study

scientific article published on 05 February 2020

Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune-checkpoint inhibitors

scientific article published on 22 February 2020

The impact of high PD-L1 expression on the surrogate endpoints and clinical outcomes of anti-PD-1/PD-L1 antibodies in non-small cell lung cancer

scientific article published on 26 December 2018

List of works by Hiroaki Akamatsu